Search research articles
Contact Us
Filters
Showing results (521-530 of 545) with videos related to
Page
of 55
Sort By:
Cancer Communications
|
June 1, 1991
Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein
G Yu, S Ahmad, A Aquino, et al.
Phytochemistry
|
October 3, 2000
Neutral taxoids from Taxus cuspidata as modulators of multidrug-resistant tumor cells
K Kosugi, J Sakai, S Zhang, et al.
International Journal of Cancer
|
October 15, 1989
Bispecific antibodies reactive with the multidrug-resistance-related glycoprotein and CD3 induce lysis of multidrug-resistant tumor cells
J Van Dijk, T Tsuruo, D M Segal, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 15, 2003
Carcinoembryonic antigen mRNA in abdominal cavity as a useful predictor of peritoneal recurrence of gastric cancer with serosal exposure
S Fujii, J Kitayama, S Kaisaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 26, 2000
[Results of molecular screening of anti-cancer agents. 8. Results of screening of possible anti-cancer agents in Japan]
T Yamori, T Ando, S Uehara, et al.
Japanese Journal of Cancer Research : Gann
|
February 1, 1996
Establishment of a hepatocyte cell line producing growth-promoting factors for liver-colonizing tumor cells
T Yamori, K Shimada, H Kanda, et al.
European Journal of Nuclear Medicine
|
February 1, 1997
In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients
S D Vecchio, A Ciarmiello, M I Potena, et al.
Journal of the National Cancer Institute
|
October 2, 1991
Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody
J W Pearson, W E Fogler, K Volker, et al.
International Journal of Cancer
|
September 30, 1993
Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein
A H Schinkel, R J Arceci, J J Smit, et al.
Cancer Research
|
June 5, 2001
Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity
Y Komatsu, K Y Tomizaki, M Tsukamoto, et al.
Page
of 55
Search research articles
Search
Showing results (521-530 of 545) with videos related to
Sort By:
Page
of 55
Cancer Communications
|
June 1, 1991
Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein
G Yu, S Ahmad, A Aquino, et al.
Phytochemistry
|
October 3, 2000
Neutral taxoids from Taxus cuspidata as modulators of multidrug-resistant tumor cells
K Kosugi, J Sakai, S Zhang, et al.
International Journal of Cancer
|
October 15, 1989
Bispecific antibodies reactive with the multidrug-resistance-related glycoprotein and CD3 induce lysis of multidrug-resistant tumor cells
J Van Dijk, T Tsuruo, D M Segal, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 15, 2003
Carcinoembryonic antigen mRNA in abdominal cavity as a useful predictor of peritoneal recurrence of gastric cancer with serosal exposure
S Fujii, J Kitayama, S Kaisaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 26, 2000
[Results of molecular screening of anti-cancer agents. 8. Results of screening of possible anti-cancer agents in Japan]
T Yamori, T Ando, S Uehara, et al.
Japanese Journal of Cancer Research : Gann
|
February 1, 1996
Establishment of a hepatocyte cell line producing growth-promoting factors for liver-colonizing tumor cells
T Yamori, K Shimada, H Kanda, et al.
European Journal of Nuclear Medicine
|
February 1, 1997
In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients
S D Vecchio, A Ciarmiello, M I Potena, et al.
Journal of the National Cancer Institute
|
October 2, 1991
Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody
J W Pearson, W E Fogler, K Volker, et al.
International Journal of Cancer
|
September 30, 1993
Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein
A H Schinkel, R J Arceci, J J Smit, et al.
Cancer Research
|
June 5, 2001
Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity
Y Komatsu, K Y Tomizaki, M Tsukamoto, et al.
Page
of 55